ATRACURIUM BESYLATE Pfizer

This product information is intended only for residents of the United States. for Health Care Professionals ATRACURIUM BESYLATE, Vial U.S. Physician Prescribing Information. See related articles. ATRACURIUM Besylate Injection, USPATRACURIUM Besylate Injection, USP . Brand Name Equivalent TRACRIUM &(TRACRIUM is a atracurium besylate Atracurium (besylate) (CAS 64228-81-5) - Cayman ChemAtracurium (besylate) is a benzylisoquinoline that acts as a neuromuscular blocking agent with slow onset and intermediate duration. 1, 2 It causes non-depolarizing block of the neuromuscular junction. 2. WARNING This product is not for human or veterinary use.

Atracurium Besilate - an overview ScienceDirect Topics

Atracurium is a mixture of 10 optical and geometric isomers. 90 The R-R 91 optical isomer in the cis-cis configuration, cisatracurium, is about 1.5 times more potent than atracurium, and does not liberate histamine at high doses. 92 Cisatracurium is seemingly primarily degraded by Hofmann elimination, pH-dependent chemical degradation, with the atracurium besylate Atracurium Besylate 99%(HPLC) Selleck AChR inhibitorDescription Atracurium Besylate (BW 33A, 51W89) is a neuromuscular blocking agent with ED95 of 0.2 mg/kg. Atracurium Besylate 99%(HPLC) Selleck AChR inhibitorDescription Atracurium Besylate (BW 33A, 51W89) is a neuromuscular blocking agent with ED95 of 0.2 mg/kg.

Atracurium Monograph for Professionals - Drugs

For continuous IV infusion, dilute atracurium besylate injection to the desired concentration (usually 0.2 or 0.5 mg/mL) in 5% dextrose, 5% dextrose and 0.9% sodium chloride, or 0.9% sodium chloride injection. Use within 24 hours. Dosage. Available as atracurium besylate; dosage expressed in terms of the salt. Atracurium Price of 10 Brands / Trade Names MedindiaDrug Name Atracurium. Atracurium(Atracurium Besylate Injection ) generic is a neuromuscular-blocking agent, used as an adjuvant in anesthesia. provides relaxation of skeletal muscles during surgery. Atracurium besylate 98% (HPLC), powder 64228-81-5Atracurium besylate 98% (HPLC), powder; CAS Number 64228-81-5; EC Number 264-743-4; Synonyms 2,2-]bis[1-[3,4 atracurium besylate

Atracurium besylate C65H82N2O18S2 - PubChem

Atracurium Besylate is a synthetic dibenzensulfonate derivative muscle relaxant, Atracurium Besylate acts as a non-depolarizing neuromuscular blocking agent, with short to intermediary duration of action and no significant cardiovascular effects. Not dependent on kidney function for elimination, it provides clinical advantages over other non atracurium besylate Atracurium besylate Uses, Interactions, Mechanism of atracurium besylateIdentification Pharmacology Interactions Chemical Identifiers References Pharmacoeconomics Properties Spectra Summary
1. Atracurium besylateis a non-depolarizing neuromuscular blocker used to facilitate endotracheal intubation and relax skeletal muscles during surgery. Generic Name
1. Atracurium besylate DrugBank Accession Number
1. DB00732 See more on go.drugbank Atracurium Besylate Injection - FDA prescribing atracurium besylateContraindications Description Structure Mechanism of action Clinical significance Prognosis Pharmacology Treatment Medical uses Usage Side effects Pathophysiology Benefits Adverse effects Interactions Toxicity Management Risks Safety Atracurium Besylate is an intermediate-duration, nondepolarizing, skeletal muscle relaxant for intravenous administration. Atracurium Besylate is designated as 2-(2-Carboxyethyl)-1,2, 3, 4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene ester. It has a molecular weight of 1,243.49, and its molecular formula is C65H82N2O18S2. The structural formula is Atracurium Besylate Injection, USP is a sterile, non-pyrogenic aqueous solution. Each mL c See more on drugs 11 mins Published Oct 19, 2017 Atracurium Besylate Injection uses, dosage, side effects atracurium besylateAtracurium Besylate is used, as an adjunct to general anaesthesia, to facilitate endotracheal intubation and to offer skeletal muscle relaxation during surgery or mechanical ventilation. The drug atracurium besylate can be used most advantageously if muscle twitch response to Cisatracurium besylate C65H82N2O18S2 - PubChemCisatracurium besylate is the (1R,1'R,2R,2'R)-diastereoisomer of atracurium besylate.Commercial preparations of atracurium are mixtures of 10 stereoisomers, of which cisatracurium generally constitutes about 15%. Cisatracurium besylate is about 3 times more potent than the mixture of atracurium isomers as a neuromuscular blocking agent, and is used as a muscle relaxant for

Cisatracurium besylate C65H82N2O18S2 - PubChem

Cisatracurium besylate is the (1R,1'R,2R,2'R)-diastereoisomer of atracurium besylate.Commercial preparations of atracurium are mixtures of 10 stereoisomers, of which cisatracurium generally constitutes about 15%. Cisatracurium besylate is about 3 times more potent than the mixture of atracurium isomers as a neuromuscular blocking agent, and is used as a muscle relaxant for Clinical Pharmacology of Atracurium Besylate (BW 33A) A atracurium besylateAtracurium, a new non-depolarizing neuromuscular blocking agent, was studied in 70 patients anesthetized with fentanyl, thiopental, and nitrous oxide-oxygen. The dose found to produce 95% twitch inhibition (ED95) was 0.2 mg/ kg. The onset time from injection to maximum depression of twitch was 4.0 minutes at this dose; the duration to 95% atracurium besylate DailyMed - ATRACURIUM BESYLATE injection, solutionAtracurium Besylate Injection, USP is a sterile, non-pyrogenic aqueous solution. Each mL contains 10 mg atracurium besylate. The pH is adjusted to 3.25 to 3.65 with benzenesulfonic acid. The multiple dose vial contains 0.9% benzyl alcohol added as a preservative.

Effect of intraurethral administration of atracurium atracurium besylate

Objective To evaluate the effect of intraurethral administration of atracurium besylate for urinary obstruction resulting from urethral plugs in male cats. Methods Forty-five male cats were divided into the treatment group (n=25), in which 4 mL atracurium besylate solution (05 mg/mL) was injected into the urethral lumen, and the control group (n=20), treated with saline. How are Nondepolarizing agents used to treat atracurium besylate?How are Nondepolarizing agents used to treat atracurium besylate?Nondepolarizing agents antagonize the neurotransmitter action of acetylcholine by binding competitively with cholinergic receptor sites on the motor end-plate. This antagonism is inhibited, and neuromuscular block reversed, by acetylcholinesterase inhibitors such as neostigmine, edrophonium, and pyridostigmine.Atracurium Besylate Injection - FDA prescribing atracurium besylate How does the muscle relaxer atracurium besylate work?How does the muscle relaxer atracurium besylate work?Atracurium Besylate is a synthetic dibenzensulfonate derivative muscle relaxant, Atracurium Besylate acts as a non-depolarizing neuromuscular blocking agent, with short to intermediary duration of action and no significant cardiovascular effects. Not dependent on kidney function for elimination, atracurium besylateAtracurium besylate C65H82N2O18S2 - PubChem

How is cisatracurium besylate used in anaesthesia?How is cisatracurium besylate used in anaesthesia?Cisatracurium besylate is about 3 times more potent than the mixture of atracurium isomers as a neuromuscular blocking agent, and is used as a muscle relaxant for endotracheal intubation, to aid controlled ventilation, and in general anaesthesia. It has a role as a muscle relaxant and a nicotinic antagonist.Cisatracurium besylate C65H82N2O18S2 - PubChem NDC 71288-701 Atracurium Besylate Atracurium Besylate

Atracurium besylate is an intermediate-duration, nondepolarizing, skeletal muscle relaxant for intravenous administration. Atracurium besylate is designated as 2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene ester. NIMBEX - cisatracurium besylate injection Abbott atracurium besylateNIMBEX (cisatracurium besylate) is a nondepolarizing skeletal muscle relaxant for intravenous administration. Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action. Cisatracurium besylate is one of 10 isomers of atracurium besylate and constitutes approximately 15% of that mixture.

Obat Atracurium Besylate - Dosis, Pemakaian, Efek Samping atracurium besylate

Penggunaan Atracurium Besylate injeksi harus dilakukan oleh tenaga medis. Intubasi endotrakea. 0.4-0.5 mg/kg disuntikkan melalui pembuluh darah vena, selanjutnya diberikan dosis 0.08-0.1 mg/kgBB. Relaksasi otot selama operasi. 0.4-0.5 mg/kgBB, selanjutnya diberikan dosis Obat Atracurium Besylate - Dosis, Pemakaian, Efek Samping atracurium besylatePenggunaan Atracurium Besylate injeksi harus dilakukan oleh tenaga medis. Intubasi endotrakea. 0.4-0.5 mg/kg disuntikkan melalui pembuluh darah vena, selanjutnya diberikan dosis 0.08-0.1 mg/kgBB. Relaksasi otot selama operasi. 0.4-0.5 mg/kgBB, selanjutnya diberikan dosis SAFETY DATA SHEET Page 1 of 5 Cisatracurium Cisatracurium (besylate) SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006 as amended by (EC) No. 1272/2008 1.1 Product Code 22959 Section 1. Identification of the Substance/Mixture and of the Company/Undertaking Product Name Cisatracurium (besylate) Company Name Cayman Chemical Company 1180 E. Ellsworth Rd. Ann Arbor, MI 48108

Side Effects of Atracurium Besylate Injection (Atracurium atracurium besylate

Atracurium Besylate Injection is a skeletal muscle relaxant used in addition to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.Atracurium besylate injection is available in generic form. Common side effects of atracurium besylate injection include: Side Effects of Atracurium Besylate Injection (Atracurium atracurium besylateAtracurium Besylate Injection is a skeletal muscle relaxant used in addition to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.Atracurium besylate injection is available in generic form. Common side effects of atracurium besylate injection include: US5684154A - Process for the preparation and isolation of atracurium besylateA process of producing atracurium besylate that substantially reduces the level of impurities in the final product and avoids the repeated use of ether is provided. In accordance with such a process, N, N'-4,10-dioxa-3,11-dioxotridecylene-1,13-bis-tetrahydropapaverine (Compound 1), methyl benzenesulfonate and a catalytic amount of an insoluble base in a solvent are combined to form a reaction atracurium besylate

atracurium besylate

atracurium besylate brand name besylate structure atracurium iv atracurium package insert cisatracurium besilate tracrium atracurium moa atracurium nursing considerations atracurium besylateatracurium besylate brand name besylate structure atracurium iv atracurium package insert cisatracurium besilate tracrium atracurium moa atracurium nursing considerations ATRACURIUM BESYLATE PfizerThis product information is intended only for residents of the United States. for Health Care Professionals ATRACURIUM BESYLATE, Vial U.S. Physician Prescribing Information. See related articles. atracurium besylateatracurium besylate brand name besylate structure atracurium iv atracurium package insert cisatracurium besilate tracrium atracurium moa atracurium nursing considerations Atracurium Besylate Injection uses, dosage, side effects atracurium besylateAtracurium Besylate is used, as an adjunct to general anaesthesia, to facilitate endotracheal intubation and to offer skeletal muscle relaxation during surgery or mechanical ventilation. The drug atracurium besylate can be used most advantageously if muscle twitch response to

Atracurium Besylate Injection - FDA prescribi

Common side effects of atracurium besylate injection include skin flushing or redness. injection site reactions. hives. itching. wheezing. shortness of breath. allergic reactions.Atracurium besylate Uses vs Side EffectsPerspectives from the webAtracurium besylate is a nondepolarizing skeletal muscle relaxant. Nondepolarizing agents antagonize the neurotransmitter action of acetylcholine by binding competitively with cholinergic receptor sites on the motor end-plate. This antagonism is inhibited, and neuromuscular block reversed, by acetylcholinesterase inhibitors such as neostigmine, edrophonium, and pyridostigmine. Atracurium can be used most advantageously if muscle twitch response to peripheral nerve stimulation is monitored to assess degree of muscle relaxation.Common Side Effects of Atracurium Besylate Inje What are the side effects of atracurium besylate?What are the side effects of atracurium besylate?Atracurium Besylate Injection is a skeletal muscle relaxantused in addition to general anesthesia, to facilitate endotracheal intubationand to provide skeletal musclerelaxation during surgery or mechanical ventilation. Atracurium besylate injection is available in genericform. Common side effects of atracurium besylate injection include:Side Effects of Atracurium Besylate Injection (Atracurium Besylate Injecti

Molecular Formula C65H82N2O18S2 PubChem CID 47320 Atracurium besylate (Concept Id C0004235)

A synthetic dibenzensulfonate derivative muscle relaxant, Atracurium Besylate acts as a non-depolarizing neuromuscular blocking agent, with short to intermediary duration of action and no significant cardiovascular effects. Not dependent on kidney function for elimination, it provides clinical advantages over other non-depolarizing, neuromuscular blocking agents.Molecular Formula C65H82N2O18S2 PubChem CID 62886 Tracrium (Atracurium Besylate) Uses, Dosage, Side Effects atracurium besylateTRACRIUM (atracurium besylate) Injection is a sterile, nonpyrogenic aqueous solution. Each mL contains 10 mg atracurium besylate. The pH is adjusted to 3.25 to 3.65 with benzenesulfonic acid. The multiple-dose vial contains 0.9% benzyl alcohol added as a preservative.

    Leava a Message: